
Eylea’s Role in Retinal Disease: Risks and Efficacy Explained
Eylea, known scientifically as aflibercept, is a biologic medicine instrumental in treating vision-compromising retinal diseases like wet age-related macular degeneration and diabetic macular edema. Despite its therapeutic value, Eylea has potential side effects that necessitate careful monitoring. Evaluations underscore the importance of understanding both mild and serious risks, with comparative safety assessments revealing no significant […]
3 min read